本文采用亲和酶标组化法对40例乳腺癌标本进行雌激素受体(ER)和孕激素受体(PR)的检测,旨在联系临床病理组织学,探讨乳腺癌ER、PR的分布及其生物学意义,为临床选择治疗方案提供参考依据。1 材料与方法 收集本院1990年8月～1991年12月乳腺癌根治术标本40例(女39例,男1例),冰冻切片。试剂采用中国科学院上海生化所酶联雌二醇、酶联孕酮试剂盒。激素受体检测采用上海医科大学刘尚廉等酶联雌二醇、酶联孕酮亲和组化检测法。ER、PR In this study, 40 cases of breast cancer specimens were detected by affinity enzyme labeling method for estrogen receptor (ER) and progesterone receptor (PR), in order to investigate the distribution of ER and PR in breast cancer with clinicopathological histology And its biological significance for the clinical choice of treatment programs provide a reference. 1 Materials and Methods Forty patients (39 males and 1 male) underwent radical mastectomy from August 1990 to December 1991 in our hospital. Frozen sections were collected. Reagents used by the Shanghai Institute of Biochemistry, Chinese Academy of Sciences enzyme estradiol, enzyme progesterone kit. Hormone receptor test using Shanghai Shang Liu Lian Lian enzyme estradiol, enzyme progesterone affinity assay. ER, PR